Vanderbilt Kennedy Center

Medication for Weight Gain in Children and Teens with ASD

Last Updated: Tuesday, June 11, 2013

Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.

Other researchers: Kevin Sanders, MD

Description

Do you have a family member that has been diagnosed with an Autism Spectrum Disorder and has experienced weight gain while taking antipsychotic medication?

The purpose of the study is to find out if the investigational drug called metformin is safe and helpful in reducing weight gain for patients with an autism spectrum disorder who are taking anti-psychotic medication. Metformin is already used safely in adults and children with diabetes.

Evaluations, study visits, and study drug are provided at no cost.

A blood draw is required at 3 separate visits.

Every participant will be given the opportunity to receive study medication.

This study is sponsored by The Autism Intervention Research Network on Physical Health as part of the Autism Treatment Network.

Participant Criteria

Children age 6– 17 with an autism spectrum disorder who are taking an atypical antipsychotic like Risperidone (risperidol), Zyprexa (Olanzapine) and have gained unwanted weight.

Compensation

Evaluations, study visits, and study drug are provided at no cost. At least $35/visit to the family.

Visit Requirements

12 visits to Vanderbilt University in Nashville, TN.

Brochure

Download Brochure

Contact Information

Sarah Marler
(615) 936-3288
sarah.marler@vanderbilt.edu

Want to Participate in this Study?

Enter your name and contact information and this study's coordinators will contact you if there are openings available.

 
 
(Optional)